Editorial: What are the therapeutic advances in gastroenterology? Opinions from world experts

Burnham, J.M. , Shults, J. , Semeao, E. , Foster, B.J. , Zemel, B.S. , Stallings, V.A. et al. (2005) Body-composition alterations consistent with cachexia in children and young adults with Crohn disease. Am J Clin Nutr 82: 413-420.

Cai, D. , Frantz, J.D. , Tawa Jr, N.E. , Melendez, P.A. , Oh, B.-C. , Lidov, H.G.W. et al. (2004) IKKbeta/ NF-kappaB activation causes severe muscle wasting in mice. Cell 119: 285-298.

Cheung, T.K. and Wong, B.C. (2008) Treatment of Helicobacter pylori and prevention of gastric cancer. J Dig Dis 9: 8-13.

De Vries, A.C. and Kuipers, E.J. (2007) Review article: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 26(Suppl 2): 25-35.

Feagan, B. , Colombel, J.-F. , Present, D.H. , Bloomfield, R. and Reinisch, W. Co-Administration of Certolizumab Pegol with Immunosuppressants and/or Corticosteroids Is Not Associated with An Increased Risk of Adverse Events with Crohn's Disease: Analysis of Pooled Data. Abstract T1141, presented at Digestive Diseases Week, San Diego, CA, USA, May 18-21, 2008.

Fock, K.M. , Talley, N. , Moayyedi, P. , Hunt, R. , Azuma, T. , Sugano, K. et al. (2008) Asia-Pacific Gastric Cancer Consensus Conference. Asia-Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 23: 351-365.

Fuccio, L. , Zagari, R.M. , Minardi, M.E. and Bazzoli, F. (2007) Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer. Aliment Pharmacol Ther 25: 133-141.

Jankowski, J. and Moayyedi, P. (2004) Re: Cost-effectiveness of aspirin chemoprevention for Barrett's esophagus. J Natl Cancer Inst 96: 885-887.

Romero, Y. (2006) Do PPIs diminish Barrett's esophagus length or cancer risk?: Commentary. Nature Clinical Practice Gastroenterology & Hepatology 3: 658-659.

Rossignol, J. , Elfert, A. and El-Gohary, Y. (2007) Interim Data from a Randomized Controlled Trial of Nitazoxanide-Peginterferon-Ribavirin, Nitazoxanide-Peginterferon and Peginterferon-Ribavirin in the Treatment of Patients with Chronic Hepatitis C Genotype 4. 58th Annual Meeting of the American Association for the Study of Liver Diseases. Boston; November 2-6, 2007. Abstract 178.

Shaheen, N.J. , Sharma, P. , Overholt, B.F. , Lightdale, C.J. , Wolfsen, H.C. , Sampliner, R.E. et al. (2008) A Randomized, Multicenter, Sham-Controlled Trial of Radiofrequency Ablation (RFA) for Subjects with Barrett's Esophagus (Be) Containing Dysplasia: Interim Results of the Aim Dysplasia Trial. Abstract 213, presented at Digestive Diseases Week, San Diego, CA, USA, May 18-21, 2008.

Sugano, K. (2007) Prevention of gastric cancer: urgent need to implement Helicobacter pylori eradication therapy as a primary preventive measure in Japan. J Gastroenterol 42(Suppl 17): 1-2.

Torres, D.M. and Hamillon, S.A. (2008) Current treatments in nonalcoholic steatohepatitis . Curr Treatment options Gastroenterol 10: 425-434.